Skip to main content

#Italy, First European imported #Human Case of an #H9N2 avian #influenza virus infection discovered in #Lombardy (Press Release, March 25 '26)

 


"Thanks to the epidemiological surveillance network active in the region, the first European {imported} case of avian influenza of the H9 subtype has been identified in a patient arriving from abroad," said the Regional Councilor for Welfare.

The Lombardy Region immediately activated coordination procedures with the Ministry of Health and the Istituto Superiore di SanitĂ  (ISS) to ensure the utmost rigor in managing the case and monitoring contacts.

The councilor added

"The patient is currently hospitalized in isolation at San Gerardo Hospital in Monza. In addition to treatment for the viral infection, the medical team is managing other comorbidities the patient is suffering from. The epidemiological investigation was promptly conducted by ATS Brianza, while the molecular analyses that allowed for the precise identification of the virus were performed by the University of Milan and confirmed by the Regional Center for Infectious Diseases (composed of the Directorate General for Welfare – Prevention Unit of the Lombardy Region, ASST Fatebenefratelli-Sacco and San Matteo di Pavia) and the ISS."

"The identification of the first European case of H9 influenza in Lombardy," ​​emphasized, "shouldn't be a cause for alarm for the public, but it is tangible proof that our prevention system is working with extreme precision. We acted very quickly." (LNews)

Source: 


Link: https://www.lombardianotizie.online/comunicato-stampa/lombardia-influenza-h9/

____

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...